As per a peer-reviewed Lancet study, the efficacy of covaxin is 77.8%
The interim results of a Phase 3 study of Covaxin, an Indian vaccine developed by Bharat Biotech and the Indian ...
The interim results of a Phase 3 study of Covaxin, an Indian vaccine developed by Bharat Biotech and the Indian ...
The results of the fourth seropositivity research undertaken by the Indian Council of Medical Research were revealed by the Centre ...
India's COVID-19 case tally crosses 35 lakh mark with a spike of 78,761 new cases and 948 deaths in the ...
© 2024 The Edge Media All Rights Reserved.
© 2024 The Edge Media All Rights Reserved.